XML 22 R10.htm IDEA: XBRL DOCUMENT

Note 4 - Other Financial Information

6 Months Ended

Jun. 30, 2023

Note 4 – Other Financial Information

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following as of June 30, 2023 and December 31, 2022 (in thousands):

	*June 30,*		*December 31,*
	*2023*		*2022*
Accounts payable	$	4,659	$	5,527
Accrued sales reserves		2,721		618
Accrued clinical expenses		2,054		2,853
Accrued research and development expenses		1,003		1,285
Accrued selling, general and administrative expenses		2,836		1,609
Accrued other expenses		3,130		491
Total accounts payable and accrued expenses	$	16,403	$	12,383

Interest and Other Income (Expense), Net

Interest and other income (expense), net consisted of the following as of June 30, 2023 and 2022 (in thousands):

	*Six Months Ended June 30,*
	*2023*			*2022*
Interest income	$	1,080		$	28
Other income (expense), net		(45	)		98
Total interest and other income (expense), net	$	1,035		$	126